Lipid hydroperoxide and cGMP are not involved in nitric oxide inhibition of steroidogenesis in bovine granulosa cells

被引:15
作者
Basini, G [1 ]
Grasselli, F [1 ]
Ponderato, N [1 ]
Bussolati, S [1 ]
Tamanini, C [1 ]
机构
[1] Univ Parma, Ist Fisiol Vet, I-43100 Parma, Italy
关键词
D O I
10.1071/RD00089
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The present study was performed to explore two of the possible signalling mechanisms through which nitric oxide (NO) inhibits steroidogenesis in bovine granulosa cells. Because cGMP is generally known to play a pivotal role in NO signal transduction, the first aim of the present study was to verify the presence of a functional NO-cGMP signalling pathway. Because non-cGMP-dependent pathways could be involved in the inhibition of steroidogenesis by NO, we examined the formation of lipid hydroperoxides (LPOs), possibly induced by NO. Using bovine granulosa cells collected from small (< 5 mm) and large (> 8 mm) follicles, the effectiveness of the NO donor s-nitroso-N-acetylpenicillamine (SNAP; 10(-3), 10(-4) and 10(-5) M) in stimulating cGMP production and the formation of LPOs was examined. The second aim of the present study was to determine whether the effects of NO on steroidogenesis could be mimicked by treatment of cells with a cGMP analogue (8-bromo-cGMP (8-Br-cGMP); 10(-3), 10(-4) and 10(-5) M) and whether these effects could be reversed by [H-1]-[1,2,3]oxadiaziolo[4,3a]quinoxaline- 1-one (ODQ; 10(-5) and 10(-4) M) an inhibitor of NO-sensitive soluble guanylate cyclase. The highest dose of SNAP used induced a significant (P<0.01) increase in cGMP levels, while other concentrations tested were ineffective. Neither concentration of ODQ used significantly inhibited basal cGMP output, while both concentrations counteracted the stimulatory effect of SNAP. Treatment of cells with 8-Br-cGMP and ODQ was ineffective in modifying steroidogenesis. Treatment with SNAP, at the three concentrations tested, had no significant effect on the level of LPOs. The present results suggest that NO inhibits steroidogenesis in bovine granulosa cells without involving cGMP and LPOs.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 57 条
[1]   Steroid regulation during apoptosis of ovarian follicular cells [J].
Amsterdam, A ;
Dantes, A ;
Hosokawa, K ;
Schere-Levy, CP ;
Kotsuji, F ;
Aharoni, D .
STEROIDS, 1998, 63 (5-6) :314-318
[2]   Is nitric oxide an autocrine modulator of bovine granulosa cell function? [J].
Basini, G ;
Baratta, M ;
Ponderato, N ;
Bussolati, S ;
Tamanini, C .
REPRODUCTION FERTILITY AND DEVELOPMENT, 1998, 10 (06) :471-478
[3]   Selenium stimulates estradiol production in bovine granulosa cells: possible involvement of nitric oxide [J].
Basini, G ;
Tamanini, C .
DOMESTIC ANIMAL ENDOCRINOLOGY, 2000, 18 (01) :1-17
[4]   Stimulation of nitric oxide-cyclic guanosine monophosphate pathway in bovine ovarian theca cells by tumor necrosis factor alpha (TNF alpha). Is this pathway implicated in the TNF alpha-induced inhibition of luteinizing hormone-stimulated prorenin production? [J].
BrunswigSpickenheier, B ;
Mukhopadhyay, AK .
BIOLOGY OF REPRODUCTION, 1997, 57 (04) :700-706
[5]  
BUECHLER WA, 1994, ANN NY ACAD SCI, V714, P151
[6]   Guanylate cyclase and the .NO/cGMP signaling pathway [J].
Denninger, JW ;
Marletta, MA .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1411 (2-3) :334-350
[7]   NITRIC-OXIDE MEDIATES INTERLEUKIN-1 INDUCED CELLULAR CYTOTOXICITY IN THE RAT OVARY - A POTENTIAL ROLE FOR NITRIC-OXIDE IN THE OVULATORY PROCESS [J].
ELLMAN, C ;
CORBETT, JA ;
MISKO, TP ;
MCDANIEL, M ;
BECKERMAN, KP .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :3053-3056
[8]   Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates [J].
Escames, G ;
Guerrero, JM ;
Reiter, RJ ;
Garcia, JJ ;
MunozHoyos, A ;
Ortiz, GG ;
Oh, CS .
NEUROSCIENCE LETTERS, 1997, 230 (03) :147-150
[9]   SPLENIC B-LYMPHOCYTE PROGRAMMED CELL-DEATH IS PREVENTED BY NITRIC-OXIDE RELEASE THROUGH MECHANISMS INVOLVING SUSTAINED BCL-2 LEVELS [J].
GENARO, AM ;
HORTELANO, S ;
ALVAREZ, A ;
MARTINEZA, C ;
BOSCA, L .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1884-1890
[10]  
Girotti AW, 1998, J LIPID RES, V39, P1529